ReviewBiomarker research2019

Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia.

Bo Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.